Free Trial

Kenvue (KVUE) Stock Forecast & Price Target

Kenvue logo
$21.77 +0.16 (+0.74%)
(As of 12/20/2024 05:40 PM ET)

Kenvue - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
8
Buy
3

Based on 12 Wall Street analysts who have issued ratings for Kenvue in the last 12 months, the stock has a consensus rating of "Hold." Out of the 12 analysts, 1 has given a sell rating, 8 have given a hold rating, and 3 have given a buy rating for KVUE.

Consensus Price Target

$22.64
3.98% Upside
According to the 12 analysts' twelve-month price targets for Kenvue, the average price target is $22.64. The highest price target for KVUE is $27.00, while the lowest price target for KVUE is $18.00. The average price target represents a forecasted upside of 3.98% from the current price of $21.77.
Get the Latest News and Ratings for KVUE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Kenvue and its competitors.

Sign Up

KVUE Analyst Ratings Over Time

TypeCurrent Forecast
12/23/23 to 12/22/24
1 Month Ago
11/23/23 to 11/22/24
3 Months Ago
9/24/23 to 9/23/24
1 Year Ago
12/23/22 to 12/23/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
8 Buy rating(s)
Hold
8 Hold rating(s)
7 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$22.64$22.64$21.56$26.50
Forecasted Upside3.98% Upside-6.00% Downside-6.36% Downside24.06% Upside
Consensus Rating
Hold
Hold
Hold
Moderate Buy

KVUE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

KVUE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Kenvue Stock vs. The Competition

TypeKenvueConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.17
2.50
2.51
Consensus RatingHoldHoldModerate Buy
Predicted Upside3.98% Upside46.09% Upside14.53% Upside
News Sentiment Rating
Positive News

See Recent KVUE News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/12/2024Barclays
3 of 5 stars
L. Lieberman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
12/12/2024Deutsche Bank Aktiengesellschaft
3 of 5 stars
 DowngradeBuy ➝ Hold$25.00 ➝ $24.00+7.96%
12/9/2024Royal Bank of Canada
4 of 5 stars
N. Modi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Moderate Buy
10/22/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$24.00 ➝ $27.00+18.11%
10/11/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$24.00 ➝ $25.00+17.15%
9/24/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$27.00+17.29%
9/23/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$20.00 ➝ $21.00-8.77%
8/7/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$20.00 ➝ $22.00+5.36%
7/10/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$21.00 ➝ $20.00+13.06%
5/8/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$20.00 ➝ $21.00+3.09%
4/11/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageUnderperform$18.00-11.02%
4/3/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Andersen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform
3/1/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy ➝ Neutral$20.00+5.24%
9/7/2023Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$28.00+25.06%
9/6/2023Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold
7/25/2023Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy
5/30/2023BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$28.00+6.46%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 05:54 AM ET.


Should I Buy Kenvue Stock? KVUE Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, December 13, 2024. Please send any questions or comments about these Kenvue pros and cons to contact@marketbeat.com.

Kenvue
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Kenvue Inc.:

  • Kenvue Inc. recently reported earnings of $0.28 per share, exceeding analysts' expectations of $0.27, indicating strong financial performance.
  • The company has a market capitalization of approximately $43.79 billion, reflecting its significant size and stability in the consumer health sector.
  • With a current stock price of $22.84, Kenvue Inc. is trading near its 52-week high of $24.46, suggesting potential for further growth.
  • Kenvue Inc. has a dividend yield of 3.59%, providing investors with a steady income stream, which is attractive in a low-interest-rate environment.
  • Analysts have a consensus price target of $22.64, indicating that the stock is currently fairly valued, with room for appreciation based on future performance.

Kenvue
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Kenvue Inc. for these reasons:

  • The company has a high dividend payout ratio of 149.09%, which may not be sustainable in the long term if earnings do not grow.
  • Kenvue Inc. experienced a slight revenue decline of 0.4% year-over-year, which could indicate challenges in maintaining growth.
  • One analyst has rated the stock as a sell, suggesting some skepticism about its future performance.
  • The stock has a relatively high price-to-earnings (P/E) ratio of 41.53, which may indicate that it is overvalued compared to its earnings.
  • Market volatility, as indicated by a beta of 1.36, suggests that Kenvue Inc.'s stock price may be more susceptible to fluctuations compared to the overall market.

KVUE Forecast - Frequently Asked Questions

According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Kenvue is $22.64, with a high forecast of $27.00 and a low forecast of $18.00.

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Kenvue in the last twelve months. There is currently 1 sell rating, 8 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" KVUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KVUE, but not buy additional shares or sell existing shares.

According to analysts, Kenvue's stock has a predicted upside of 3.98% based on their 12-month stock forecasts.

Over the previous 90 days, Kenvue's stock had 2 upgrades and 2 downgrades by analysts.

Analysts like Kenvue less than other "consumer staples" companies. The consensus rating score for Kenvue is 2.17 while the average consensus rating score for "consumer staples" companies is 2.50. Learn more on how KVUE compares to other companies.


This page (NYSE:KVUE) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners